Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer
Status:
Terminated
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing. Dietary
supplements, such as phytochemicals, may stop or delay the development of breast cancer. It
is not yet known whether giving docetaxel together with a phytochemical is more effective
than giving docetaxel alone in treating patients with breast cancer.
PURPOSE: This randomized phase II trial is studying how well giving docetaxel together with a
phytochemical works compared with giving docetaxel alone as first- or second-line therapy in
treating patients with breast cancer.